T1	PrimaryOutcome 1047 1081	change in overall symptom severity
A1	Modification T1 Modified
T2	TimeFrame 1082 1094	over 14 days
R1	MeasuredAt Arg1:T1 Arg2:T2	
T3	PrimaryOutcome 281 349	not hospitalized, hospitalized, or intensive care unit stay or death
A2	Modification T3 Original
T4	TimeFrame 268 277	by day 14
R2	MeasuredAt Arg1:T3 Arg2:T4	
T5	SecondaryOutcome 377 393	symptom severity
T6	TimeFrame 394 413	at day 5 and day 14
R3	MeasuredAt Arg1:T5 Arg2:T6	
T7	SecondaryOutcome 449 501	nominal incidence of all hospitalizations and deaths
T8	SecondaryOutcome 507 545	incidence of study medicine withdrawal
T9	OtherOutcome 2144 2164	medication adherence
T10	OtherOutcome 2166 2181	adverse effects
T11	OtherOutcome 2183 2225	presence and severity of COVID-19 symptoms
T12	OtherOutcome 2227 2248	COVID-19 test results
T13	OtherOutcome 2254 2276	hospitalization status
T14	TimeFrame 2053 2127	on days 1 (medication start date), 3, 5 (medication stop date), 10, and 14
R4	MeasuredAt Arg1:T9 Arg2:T14	
R5	MeasuredAt Arg1:T10 Arg2:T14	
R6	MeasuredAt Arg1:T11 Arg2:T14	
R7	MeasuredAt Arg1:T12 Arg2:T14	
R8	MeasuredAt Arg1:T13 Arg2:T14	
T15	OtherOutcome 2536 2569	Medication-related adverse events
